IQVIA Holdings Inc.
NYSE:IQVMedical - Diagnostics & Research
-$3.13 today
- Market cap
- $42.49B
- Beta
- 1.22
- P/E (TTM)
- 20.4
- EPS (TTM)
- $8.22
Volume 1.40M
Average 1.62M
IQV Other Stockholders Equity
Equity items not reported separately, such as additional paid-in capital or treasury stock.
IQVIA Holdings Inc.NYSE: IQV
Other Stockholders Equity · Q2 FY2026 · quarter ended Jun 2026
Other stockholders equity remains negative
Q2 FY2026 other stockholders equity was $0, compared with $0 a year earlier.
Context
- Other stockholders equity amounted to 0.0% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
- Other stockholders equity increased in 1 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Other Stockholders Equity history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Other Stockholders Equity | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | +100.0% |
| FY2022 | 2022-12-31 | (10.9B) | — |
| FY2021 | 2021-12-31 | 0 | — |
Other Stockholders Equity vs competitors
How IQV compares with its peers on the latest reported figures
- IQV's Jun 2026 other stockholders equity of $0 is the 2nd highest of the 9 companies compared; the peer median is $0.
- Other stockholders equity amounts to 0.0% of total assets for IQV, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
FTREFortrea Holdings Inc. | Jun 2026 | $2.14B | — | — | 78.8% |
| Jun 2026 | $0 | — | — | 0.0% | |
| Jul 2026 | $0 | — | — | 0.0% | |
| Sep 2026 | $0 | — | — | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Sep 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding IQV) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for IQV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.37B | 1.22B | 1.38B | 1.7B | 1.98B |
| Short-term Investments | 111M | 93M | 120M | 141M | 161M |
| Net Receivables | 2.61B | 2.96B | 3.41B | 3.24B | 3.43B |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 521M | 561M | 546M | 592M | 519M |
| Total Current Assets | 4.76B | 4.98B | 5.6B | 5.83B | 6.25B |
| Property, Plant & Equipment (Net) | 903M | 863M | 819M | 773M | 823M |
| Goodwill | 13.3B | 13.92B | 14.57B | 14.71B | 16.62B |
| Intangible Assets | 4.94B | 4.82B | 4.84B | 4.5B | 4.96B |
| Long-term Investments | 164M | 162M | 239M | 374M | 432M |
| Tax Assets | 124M | 118M | 166M | 194M | 357M |
| Other Non-current Assets | 491M | 472M | 455M | 520M | 505M |
| Total Non-current Assets | 19.93B | 20.36B | 21.09B | 21.07B | 23.7B |
| Total Assets | 24.69B | 25.34B | 26.68B | 26.9B | 29.94B |
| Account Payables | 621M | 645M | 709M | 736M | 3.75B |
| Short-term Debt | 91M | 152M | 718M | 1.15B | 1.84B |
| Tax Payables | 137M | 161M | 116M | 156M | 0 |
| Deferred Revenue | 1.83B | 1.8B | 1.8B | 1.78B | 2.12B |
| Other Current Liabilities | 1.15B | 1.13B | 1.26B | 1.1B | 489M |
| Total Current Liabilities | 5.24B | 5.58B | 6.49B | 6.96B | 8.34B |
| Long-term Debt | 12.03B | 12.6B | 12.96B | 12.84B | 14.11B |
| Deferred Tax Liabilities | 410M | 464M | 202M | 196M | 179M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 649M | 671M | 698M | 668M | 463M |
| Total Non-current Liabilities | 13.41B | 13.99B | 14.08B | 13.88B | 14.98B |
| Total Liabilities | 18.65B | 19.57B | 20.57B | 20.83B | 23.31B |
| Common Stock | 3M | 10.9B | 3M | 3M | 11.38B |
| Retained Earnings | 2.24B | 3.33B | 4.69B | 6.07B | 7.43B |
| Accumulated OCI | (406M) | (727M) | (867M) | (1.04B) | (943M) |
| Other Stockholders Equity | 0 | (10.9B) | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 127M |
| Total Equity | 6.04B | 5.77B | 6.11B | 6.07B | 6.63B |
| Total Debt | 12.44B | 13.01B | 13.9B | 14.16B | 16.17B |
| Net Debt | 11.07B | 11.8B | 12.52B | 12.45B | 14.19B |
IQVIA Holdings Inc.
NYSE:IQV
Intrinsic Alpha fair value
Locked
Current Price
$257.84
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.